Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
株式のランク #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
株価
$0.00162013
最終同期: 2025-01-03
時価総額
$156.25K
変化(1日)
0.36%
変化(1年)
0.00%
SE
取引 Cyxone AB (publ) (CYXO)

カテゴリー

Cyxone AB (publ)(CYXO)の株式分割履歴
Cyxone AB (publ)株(シンボル:CYXO)は合計で2回の株式分割を実施しました。
最新の株式分割はDec 28, 2021に行われました。
Oct 03, 2018より前に購入されたCYXO株は、現在1.12682CYXO株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2021-12-28 103:100 x1.03 x1.12682
2018-10-03 547:500 x1.094 x1.094
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE